Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tipiracil hydrochloride (MA-1 hydrochloride) 是一种胸苷磷酸化酶抑制剂,是抗癌候选药物 TAS-102 中的活性成分之一,用于癌症研究。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 196 | 现货 | ||
5 mg | ¥ 452 | 现货 | ||
10 mg | ¥ 659 | 现货 | ||
25 mg | ¥ 1,090 | 现货 | ||
50 mg | ¥ 1,620 | 现货 | ||
100 mg | ¥ 2,420 | 现货 | ||
200 mg | ¥ 3,580 | 现货 | ||
500 mg | ¥ 5,730 | 现货 |
产品描述 | Tipiracil hydrochloride (MA-1 hydrochloride) is a thymidine phosphorylase inhibitor (TPI). Tipiracil hydrochloride is one of the active components in TAS-102, which is an anticancer drug candidate currently in clinical trials. |
体外活性 | Tipiracil has an antiangiogenic effect that also inhibits proliferation of endothelial cells[1]. Tipiracil is a potent inhibitor of thymidine phosphorylase, which is the enzyme that degrades FTD[2]. |
激酶实验 | In vitro kinase inhibition assays: Kinase activity for PI3K isoforms is measured as the percentage of ATP consumed following the kinase reaction using luciferase–luciferin-coupled chemiluminescence, with ATP concentrations approximately equal to the Km for each respective kinase. Kinase reactions are initiated by combining test compounds, ATP and kinase in a 20 μL volume. PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ final enzyme concentrations are 0.5, 8, 20, and 2 nM, respectively. Of note, 0.5 μL dimethyl sulfoxide (DMSO) containing varying concentrations of the test compound is mixed with 10 μL enzyme solution (2×concentration). Kinase reactions are initiated by the addition of 10 μL of liver phosphatidylinositol and ATP solution (2×concentration). Assay concentrations for VPS34, ATP, and phosphatidylinositol are 40 nM, 1 μM, and 5 μM, respectively |
别名 | MA-1 hydrochloride, 盐酸替吡嘧啶 |
分子量 | 279.12 |
分子式 | C9H12Cl2N4O2 |
CAS No. | 183204-72-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 50 mg/mL(179.13 mM)
DMSO: 50 mg/mL (179.13 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 3.5827 mL | 17.9134 mL | 35.8269 mL | 89.5672 mL |
5 mM | 0.7165 mL | 3.5827 mL | 7.1654 mL | 17.9134 mL | |
10 mM | 0.3583 mL | 1.7913 mL | 3.5827 mL | 8.9567 mL | |
20 mM | 0.1791 mL | 0.8957 mL | 1.7913 mL | 4.4784 mL | |
50 mM | 0.0717 mL | 0.3583 mL | 0.7165 mL | 1.7913 mL | |
100 mM | 0.0358 mL | 0.1791 mL | 0.3583 mL | 0.8957 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Tipiracil hydrochloride 183204-72-0 Cell Cycle/Checkpoint DNA Damage/DNA Repair Nucleoside Antimetabolite/Analog Inhibitor Tipiracil inhibit MA-1 hydrochloride MA 1 Hydrochloride 盐酸替吡嘧啶 MA-1 Hydrochloride MA1 Hydrochloride Tipiracil Hydrochloride inhibitor